Altimmune Inc
ALT
Market Cap$430.51M
Close$
$0.50
91.7% downside
Current Fair Value
91.7% downsideOvervalued by 91.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $430.51 Million |
|---|---|
| Enterprise Value | $395.26 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.34 |
| Beta | 1.12 |
| Outstanding Shares | 71,260,875 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.19 |
|---|---|
| PEG | -39.84 |
| Price to Sales | - |
| Price to Book Ratio | 6.01 |
| Enterprise Value to Revenue | 7601.18 |
| Enterprise Value to EBIT | -3.97 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg